Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

so assuming money isn't an issue what could it be with all the testing/retesting, the lab successes the Phase II's the company has completed on B?

It's probably that Phase 2 COVID trial that failed last year that put a damper on things. We had stellar COVID preclinical data but then it bombed in the trial. Now, every single bit of preclinical anti-viral data is of dubious usefulness until we prove one good in the clinic.

Remember, it's being touted by some as the new SOC drug. What pharma wouldn't want that? Is big pharma that obtuse to have the next $M/$B drug right there for the taking?

You can rest assured that any big pharma that has looked at Brilacidin has a better understanding of it's potential, both in the clinic and in the market, than does Leo or anyone at IPIX or on these boards.

Take from that what you will. When our own CEO is investing in lasers instead of our pharma pipeline it tells you all you need to know.

In 2015 I invested in a promising pharmaceutical company. Now it feels like I essentially just own shares in a Family Office.